Marianne P. Allen

Array ( [id] => 2801202 [patent_doc_number] => 05147643 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-15 [patent_title] => 'DNA sequences encoding human t-PA substituted at position 275 or at positions 275 and 277 and pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 7/741120 [patent_app_country] => US [patent_app_date] => 1991-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 16 [patent_no_of_words] => 12341 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/147/05147643.pdf [firstpage_image] =>[orig_patent_app_number] => 741120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2909038 [patent_doc_number] => 05227302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-13 [patent_title] => 'DNA encoding platelet derived endothelial cell growth factor (PD-ECGF)' [patent_app_type] => 1 [patent_app_number] => 7/742092 [patent_app_country] => US [patent_app_date] => 1991-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 35 [patent_no_of_words] => 12431 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/227/05227302.pdf [firstpage_image] =>[orig_patent_app_number] => 742092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2978217 [patent_doc_number] => 05204255 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-20 [patent_title] => 'Hybrid tissue plasminogen activator/urokinase polypeptides' [patent_app_type] => 1 [patent_app_number] => 7/726129 [patent_app_country] => US [patent_app_date] => 1991-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 34 [patent_no_of_words] => 18858 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/204/05204255.pdf [firstpage_image] =>[orig_patent_app_number] => 726129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4366701 [patent_doc_number] => 06287792 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology' [patent_app_type] => 1 [patent_app_number] => 7/716062 [patent_app_country] => US [patent_app_date] => 1991-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 9235 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287792.pdf [firstpage_image] =>[orig_patent_app_number] => 716062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3043548 [patent_doc_number] => 05334532 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-02 [patent_title] => 'PDGF-B fusion protein, vectors, and host cells for use in production thereof' [patent_app_type] => 1 [patent_app_number] => 7/675885 [patent_app_country] => US [patent_app_date] => 1991-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6545 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/334/05334532.pdf [firstpage_image] =>[orig_patent_app_number] => 675885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2976840 [patent_doc_number] => 05182375 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-26 [patent_title] => 'DNA encoding follistatin' [patent_app_type] => 1 [patent_app_number] => 7/708753 [patent_app_country] => US [patent_app_date] => 1991-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 6782 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/182/05182375.pdf [firstpage_image] =>[orig_patent_app_number] => 708753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2915115 [patent_doc_number] => 05234686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-10 [patent_title] => 'Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 7/709064 [patent_app_country] => US [patent_app_date] => 1991-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4038 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/234/05234686.pdf [firstpage_image] =>[orig_patent_app_number] => 709064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3092887 [patent_doc_number] => 05298400 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-29 [patent_title] => 'Polynucleotide constructs for secreted glycosylated plasminogen activator inhibitor-2 (PAI-2)' [patent_app_type] => 1 [patent_app_number] => 7/679052 [patent_app_country] => US [patent_app_date] => 1991-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 13299 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/298/05298400.pdf [firstpage_image] =>[orig_patent_app_number] => 679052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2930780 [patent_doc_number] => 05188943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-23 [patent_title] => 'Method of producing high molecular weight human fibroblast growth factors' [patent_app_type] => 1 [patent_app_number] => 7/686812 [patent_app_country] => US [patent_app_date] => 1991-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5264 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/188/05188943.pdf [firstpage_image] =>[orig_patent_app_number] => 686812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697231 [patent_doc_number] => 05618924 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'BMP-2 products' [patent_app_type] => 1 [patent_app_number] => 7/655579 [patent_app_country] => US [patent_app_date] => 1991-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8742 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618924.pdf [firstpage_image] =>[orig_patent_app_number] => 655579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4213096 [patent_doc_number] => 06110700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'PRAD1 cyclin and its cDNA' [patent_app_type] => 1 [patent_app_number] => 7/667711 [patent_app_country] => US [patent_app_date] => 1991-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 9806 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110700.pdf [firstpage_image] =>[orig_patent_app_number] => 667711 [rel_patent_id] =>[rel_patent_doc_number] =>)